Madrigal Pharmaceuticals, Inc. Share Price & Technical Analysis
MDGL · $517.3 (+0.71%)
Healthcare / Biotechnology
$517.3
+0.71%
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
0% return in May, -5% avg return in past 3 year May month.
-8% return in 2026, 40% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -16% | -11% | 22% | -3% | 0% | – | – | – | – | – | – | – | -8% |
| 25 | 8% | 5% | -1% | 1% | -21% | 9% | 1% | 47% | 5% | -7% | 42% | -2% | 85% |
| 24 | -6% | 8% | 12% | -24% | 16% | 18% | 3% | -13% | -14% | 22% | 19% | -5% | 37% |
| 23 | -2% | -6% | -11% | 27% | -11% | -17% | -10% | -12% | -19% | -10% | 54% | 15% | -3% |
| 22 | -33% | 61% | 5% | -29% | -5% | 8% | -13% | 15% | -9% | 6% | -3% | 311% | 315% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Uptrend · Uptrend
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$11.46B
P/E ratio
—
52W high
$615.0
52W low
$265.0
Volume
1,60,813
Beta
-1.04
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Madrigal Pharmaceuticals, Inc. share price today?
- Madrigal Pharmaceuticals, Inc. (MDGL) last traded around $517.3 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does MDGL have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for MDGL. Download the app for real-time alerts.
- How can I analyze Madrigal Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.